Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

December 17, 2020

FDA Grants Stroke Prevention Indication to Ticagrelor

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

November 06, 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

October 14, 2020

Study Affirms Thrombotic Risk in COVID-19

News Daily News

Study Affirms Thrombotic Risk in COVID-19

October 01, 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

August 31, 2020

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

News Daily News

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

July 21, 2020

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

March 16, 2020

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

February 28, 2020

Outcome Differences Between Men and Women With PAD: EUCLID Insights

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

February 11, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.